| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0065-230X(08)60331-0 |
| P698 | PubMed publication ID | 4898911 |
| P2093 | author name string | I. Hellström | |
| K. E. Hellström | |||
| P2860 | cites work | Cell-Bound Immunity to Autologous and Syngeneic Mouse Tumors Induced by Methylcholanthrene and Plastic Discs | Q72216424 |
| Inhibition of tumor growth by confrontation with incompatible cells.Possible surveillance mechanism against neoplasia | Q72218548 | ||
| A colony inhibition (CI) technique for demonstration of tumor cell destruction by lymphoid cellsin vitro | Q72246385 | ||
| Cytotoxic Effect of Lymphocyte-Antigen Interaction in Delayed Hypersensitivity | Q72246984 | ||
| An alteration in tumor histocompatibility induced by neuraminidase | Q72305044 | ||
| Studies on allogeneic inhibition III. Inhibition of mouse tumor cell colony formation in vitro by contact with lymphoid cells containing foreign H-2 antigens | Q72329938 | ||
| Effect of leukocytes on transplantability of human cancer | Q72816150 | ||
| Clinical immunologic study of malignant disease: response to tumor transplants and transfer of leukocytes | Q72821917 | ||
| Development of tumor lines with decreased sensitivity to allogeneic inhibition | Q72827021 | ||
| One-way stimulation in mixed leukocyte cultures | Q72851951 | ||
| Induced adaptation in a tumor: specificity of the change | Q73298624 | ||
| Passive transfer of transplantation immunity | Q73446523 | ||
| Some recent work on tumor immunity | Q74317456 | ||
| Homotransplantation of human cell lines | Q74356048 | ||
| Studies on the response of the regional lymph node to skin homografts | Q74443540 | ||
| Immunochemical changes in chicken serum during development of Rous sarcoma | Q75758931 | ||
| Antigenic Properties of Other Experimental Tumors | Q76486448 | ||
| PRELIMINARY OBSERVATIONS ON TREATMENT OF ADVANCED CANCER BY INJECTION OF ALLOGENEIC SPLEEN CELLS | Q76501523 | ||
| IMMUNE RESPONSE AND MITOSIS OF HUMAN PERIPHERAL BLOOD LYMPHOCYTES IN VITRO | Q76578548 | ||
| THE REACTION OF IMMUNOLOGICALLY ACTIVATED LYMPHOID CELLS AGAINST HOMOLOGOUS LYMPHOID CELLS AGAINST HOMOLOGOUS TARGET TISSUE CELLS IN VITRO | Q76626849 | ||
| AN IMMUNOLOGICAL METHOD OF INCREASING THE SENSITIVITY OF PRIMARY SARCOMAS TO LOCAL IRRADIATION WITH X RAYS | Q76675853 | ||
| TREATMENT OF PRIMARY FIBROSARCOMA IN THE RAT WITH IMMUNE LYMPHOCYTES | Q76846083 | ||
| IMMUNOLOGICAL RESPONSES OF HUMAN LYMPHOCYTES IN VITRO | Q77086463 | ||
| CONTACT-INDUCED CYTOTOXICITY BY LYMPHOID CELLS CONTAINING FOREIGN ISOANTIGENS | Q77148772 | ||
| SPECIFIC COMPLEMENT-FIXING ANTIGENS IN POLYOMA TUMORS AND TRANSFORMED CELLS | Q78297963 | ||
| RELATIONSHIP BETWEEN HUMORAL AND CELLULAR ISOANTIBODIES. I. INABILITY OF HUMORAL ISOANTIBODIES TO PREVENT THE CYTOTOXIC EFFECT OF IMMUNE LYMPHOCYTES | Q78330481 | ||
| QUANTITATIVE TITRATIONS OF MOUSE H-2 ANTIBODIES USING Cr51-LABELLED TARGET CELLS | Q78330506 | ||
| A DEFECT IN CELLULAR IMMUNITY DURING THE INCUBATION PERIOD OF PASSAGE A LEUKEMIA IN C3H MICE | Q78494339 | ||
| NEW SURFACE ANTIGEN IN CELLS TRANSFORMED BY SIMIAN PAPOVAVIRUS SV40 | Q78500905 | ||
| Histocompatibility changes in tumors | Q78600569 | ||
| Delayed Sensitivity and Homograft Sensitivity | Q78817592 | ||
| Absence of Gene Interaction in Mouse Hybrids, Revealed by Studies of Immunological Tolerance and Homotransplantation | Q78836230 | ||
| A Theory of Delayed Hypersensitivity | Q78945086 | ||
| Further studies on the induced resistance against isotransplantation of polyoma tumors | Q79420150 | ||
| Tuberculin-induced mitosis in peripheral blood leucocytes | Q79461144 | ||
| In vitro cell migration as a model for delayed hypersensitivity | Q79485272 | ||
| Histoincompatibility associated with the X chromosome in mice | Q79584460 | ||
| The immunological basis for non-infective Rous sarcomas | Q79641470 | ||
| QUANTITATIVE STUDIES ON THE BEHAVIOR OF SENSITIZED LYMPHOCYTES IN VITRO : I. RELATIONSHIP OF THE DEGREE OF DESTRUCTION OF HOMOLOGOUS TARGET CELLS TO THE NUMBER OF LYMPHOCYTES AND TO THE TIME OF CONTACT IN CULTURE AND CONSIDERATION OF THE EFFECTS OF | Q84805131 | ||
| Cancer Research | Q326097 | ||
| Lymphocyte in vitro cytotoxicity: characterization of human lymphotoxin | Q24644778 | ||
| Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. 3. Analysis of mechanism | Q24679391 | ||
| DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES | Q24679675 | ||
| The homograft reaction | Q28181712 | ||
| Immunological Recognition of Self: Such recognition suggests a relationship with processes through which functional integrity is maintained | Q29395585 | ||
| Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction | Q33798564 | ||
| Hu-1: Major Histocompatibility Locus in Man | Q34221435 | ||
| "Intrinsic" Immunological Tolerance in Allophenic Mice | Q34244441 | ||
| LYMPHOCYTE INTERACTION: A POTENTIAL HISTOCOMPATIBILITY TEST IN VITRO. | Q34256002 | ||
| Studies on the immunological response to foreign tumor transplants in the mouse. I. The role of lymph node cells in conferring immunity by adoptive transfer | Q35232044 | ||
| IMMUNOLOGY OF EXPERIMENTAL TUMORS. | Q35434728 | ||
| IMMUNOLOGICAL FACTORS IN THE PROCESS OF CARCINOGENESIS | Q35447335 | ||
| EFFECTS OF CARCINOGENS ON IMMUNE PROCESSES | Q35447350 | ||
| IMMUNOLOGY OF THE CANCER CELL: TUMOUR-SPECIFIC ANTIGENS | Q35517844 | ||
| CARCINOGEN-INDUCED TOLERANCE TO HOMOTRANSPLANTATION. | Q35519718 | ||
| The use of immunologically competent cells in the treatment of cancer: experiments with a transplantable mouse tumour | Q36126450 | ||
| Studies on the immunological response to foreign tumor transplants in the mouse. II. The relation between hemagglutinating antibody and graft resistance in the normal mouse and mice pretreated with tissue preparations | Q36262766 | ||
| DEPRESSION BY ANTIBODY OF THE IMMUNE RESPONSE TO HOMOGRAFTS AND ITS ROLE IN IMMUNOLOGICAL ENHANCEMENT. | Q36264839 | ||
| Immunological determinants of polyoma virus oncogenesis | Q36265732 | ||
| Quantitative studies of the sensitivity of normal and neoplastic mouse cells to the cytotoxic action of isoantibodies | Q36265818 | ||
| Antibody formation initiated in vitro. II. Antibody synthesis in x-irradiated recipients of diffusion chambers containing nucleic acid derived from macrophages incubated with antigen | Q36266262 | ||
| Autosensitization reaction in vitro. Contactual agglutination of sensitized lymph node cells in brain tissue culture accompanied by destruction of glial elements | Q36266293 | ||
| DETECTION OF SPECIFIC ANTIGEN IN SV40-TRANSFORMED CELLS BY IMMUNOFLUORESCENCE | Q36266598 | ||
| QUANTITATIVE STUDIES ON THE BEHAVIOR OF SENSITIZED LYMPHOCYTES IN VITRO. II. INHIBITORY INFLUENCE OF THE IMMUNE SUPPRESSOR, IMURAN, ON THE DESTRUCTIVE REACTION OF SENSITIZED LYMPHOID CELLS AGAINST HOMOLOGOUS TARGET CELLS | Q36267550 | ||
| Specific carcinoembryonic antigens of the human digestive system | Q36267788 | ||
| In vitro demonstration of cellular sensitivity in allergic encephalomyelitis | Q36267863 | ||
| On the nature of transplantation immunity in the adenovirus tumor system | Q36268416 | ||
| In vitro demonstration of humoral and cell-bound immunity against common specific transplantation atigen(s) of adenovirus 12-induced mouse and hamster tumors | Q36268442 | ||
| Studies on the heterologous immunogenicity of a methanol-insoluble fraction of attenuated tubercle bacilli (BCG). II. Protection against tumor isografts | Q36268609 | ||
| Quantitative studies on the mixed lymphocyte interaction in rats. II. Relationship of the proliferative response to the immunologic status of the donors | Q36268824 | ||
| Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro | Q36269060 | ||
| Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. I. Characterization of the phenomenon | Q36269434 | ||
| DEMONSTRATION OF MOUSE ISOANTIGENS AT THE CELLULAR LEVEL BY THE FLUORESCENT ANTIBODY TECHNIQUE. | Q36334200 | ||
| Spleen cell proliferation in response to homologous antigens studied in congenic resistant strains of mice | Q36334593 | ||
| Prevention of SV40 virus oncogenesis in hamsters. I. Tumor resistance induced by human cells transformed by SV40 | Q36377957 | ||
| SPECIFIC ADENOVIRUS COMPLEMENT-FIXING ANTIGENS IN VIRUS-FREE HAMSTER AND RAT TUMORS | Q36399289 | ||
| Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction | Q36460788 | ||
| Prevention of virus-induced neoplasms in mice through passive transfer of immunity by sensitized syngeneic lymphoid cells | Q36466158 | ||
| Demonstration of cell-bound and humoral immunity against neuroblastoma cells | Q36472164 | ||
| Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens | Q37422761 | ||
| Antigenic structure of chemically-induced hepatomas | Q39889375 | ||
| Thymic function and carcinogenesis | Q39889670 | ||
| Colicins and related bacteriocins | Q39964306 | ||
| Lymphocytes and Transplantation Immunity | Q39969659 | ||
| Cellular resistance to tumours | Q40053403 | ||
| Cytotoxic potential of stimulated human lymphocytes | Q41964126 | ||
| Passive transfer of transplantation immunity. I. Tritiated lymphoid cells. II. Lymphoid cells in millipore chambers | Q42015039 | ||
| ANTAGONISTIC EFFECTS OF HUMORAL ISOANTIBODIES ON THE IN VITRO CYTOTOXICITY OF IMMUNE LYMPHOID CELLS | Q42028764 | ||
| The mixed lymphocyte reaction: an in vitro test for tolerance | Q42190727 | ||
| EFFECTS OF ALLERGIC CONTACT DERMATITIS ON BASAL CELL EPITHELIOMAS. | Q42449768 | ||
| FURTHER STUDIES ON ADOPTIVE TRANSFER OF SENSITIVITY TO SKIN HOMOGRAFTS | Q42827807 | ||
| THE STIMULATION OF DNA SYNTHESIS IN CULTURES OF RABBIT LYMPH NODE AND SPLEEN CELL SUSPENSIONS BY HOMOLOGOUS CELLS | Q42829689 | ||
| Further studies of the stimulation of DNA synthesis in cultures of spleen cell suspensions by homologous cells in inbred strains of mice and rats | Q42830466 | ||
| Cytotoxicity by nonimmune allogeneic lymphoid cells. Specific suppression by antibody treatment of the lymphoid cells | Q42831823 | ||
| Human Osteosarcomas: Immunologic Evidence Suggesting an Associated Infectious Agent | Q43459934 | ||
| INTERRUPTION OF SV-40 VIRUS TUMORIGENESIS USING IRRADIATED HOMOLOGOUS TUMOR ANTIGEN. | Q43579954 | ||
| Transformation of human lymphocytes: inhibition by homologous alpha globulin | Q43629971 | ||
| The masking of antigens on trophoblast and cancer cells | Q43938298 | ||
| HOMOGRAFT TARGET CELLS: SPECIFIC DESTRUCTION IN VITRO BY CONTACT INTERACTION WITH IMMUNE MACROPHAGES. | Q44052966 | ||
| MOLONEY VIRUS-INDUCED LEUKEMIAS OF MICE: MEASUREMENT IN VITRO OF SPECIFIC ANTIGEN. | Q45241335 | ||
| IMMUNOLOGICAL DETERMINANTS OF ONCOGENESIS IN HAMSTERS INFECTED WITH SV40 VIRUS. | Q45713941 | ||
| TUMOR IMMUNITY IN HAMSTERS INFECTED WITH ADENOVIRUS TYPE 12 OR SIMIAN VIRUS 40. | Q45713998 | ||
| Resistance of polyoma virus immune animals to transplanted polyoma tumors. | Q45718320 | ||
| Transplant immunity to polyoma virus-induced tumor cells. IV. A polyoma strain defective in transplant antigen induction | Q45824537 | ||
| Variation of antigenic characteristics between different mouse lymphomas induced by the Moloney virus | Q45824995 | ||
| Protective activity of fractions of tubercle bacilli against isologous tumours in mice. | Q52625543 | ||
| Effect of BCG and allogeneic tumor cells on adenovirus type 12 tumorigenesis in mice. | Q53609154 | ||
| Applications of Iso-Immune Cytolysis Using Radiolabelled Target Cells | Q58955033 | ||
| Induction of Immunity and of Unresponsiveness to Parental Marrow Grafts in Adult F1 Hybrid Mice | Q58956448 | ||
| Repression of Growth, and Subsequent Adaptation, of A Parental Strain Tumour in Genetically Compatible F1 Hybrid Mice | Q58957150 | ||
| Demonstration of Syngeneic Preference In Vitro | Q58960090 | ||
| Phytohæmagglutinin-Induced Cytotoxic Action of Normal Lymphoid Cells on Cells in Tissue Culture | Q58960240 | ||
| Inhibition of DNA Synthesis of Target Cells in vitro by Sensitized Lymphocytes | Q58961963 | ||
| Effect on Tumour Growth in Syngeneic Recipients of Antibodies Against Tumour-Specific Antigens in Methylcholanthrene-Induced Mouse Sarcomas | Q58962452 | ||
| Plaque-Formation by Non-Immune and X-Irradiated Lymphoid Cells on Monolayers of Mouse Embryo Cells | Q58976452 | ||
| Allogeneic Inhibition of Tumour Cells by in vitro Contact with Cells Containing Foreign H-2 Antigens | Q58981438 | ||
| Distinction Between the Effects of Antiviral and Anticellular Polyoma Antibodies on Polyoma Tumour Cells | Q58986947 | ||
| Phytohaemagglutinin-induced Cytotoxic Action of Unsensitized Immunologically Competent Cells on Allogeneic and Xenogeneic Tissue Culture Cells | Q58992850 | ||
| Hyperploidy Effect of Lymphocyte Extract on Fibroblasts In Vitro | Q58996415 | ||
| In vitro Cytotoxic Effect of Lymphoid Cells from Mice Immunized with Allogeneic Tissue | Q59059826 | ||
| Genetic Studies of the Relationship of Tumour–Host Cells: Detection of an Allelic Difference at a Single Gene Locus in a Small Fraction of a Large Tumour-Cell Population | Q59074968 | ||
| Cellular and Humoral immunity to Different Types of Human Neoplasms | Q59074976 | ||
| Quantitative Studies on Tissue Transplantation Immunity. II. The Origin, Strength and Duration of Actively and Adoptively Acquired Immunity | Q59594812 | ||
| Differential Behaviour of Transplanted Mouse Lymphoma Lines in Genetically Compatible Homozygous and F1 Hybrid Mice | Q60087138 | ||
| Mechanism of a Reaction in Vitro Associated with Delayed-Type Hypersensitivity | Q61772241 | ||
| Demonstration of H-2 isoantigens and polyoma specific tumor antigens by measuring colony formation in vitro | Q68552168 | ||
| A rapid in vivo assay for SV40 tumor immunity in hamsters | Q68587880 | ||
| Tumor-Specific Immune Mechanisms | Q69841639 | ||
| Factors influencing growth of parental marrow grafts in irradiated F1 hybrid mice | Q69841885 | ||
| In vitro demonstration of tumor-specific antigens in spontaneous mammary tumors of mice | Q69889786 | ||
| Immunological deficiency and malignant lymphoma | Q70902063 | ||
| Host resistance to cancer. Clinical experiments by homotransplants, autotransplants and admixture of autologous leucocytes | Q71158573 | ||
| Tumor antigens | Q71186926 | ||
| Chromosomal abnormalities induced in vitro by extracts of mouse allogeneic lymphocytes | Q72027477 | ||
| In vitro studies of immune reactions against autochthonous and syngeneic mouse tumors induced by methylcholanthrene and plastic discs | Q72117392 | ||
| Chromosomal breakage induced by extracts of human allogeneic lymphocytes | Q72209833 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 167-223 | |
| P577 | publication date | 1969-01-01 | |
| P1433 | published in | Advances in Cancer Research | Q3113522 |
| P1476 | title | Cellular Immunity Against Tumor Antigens | |
| P478 | volume | 12 |
| Q68632773 | "Unblocking" serum activity in vitro in the polyoma system may correlate with antitumour effects of antiserum in vivo |
| Q53895613 | A defect of cellular immunity in xeroderma pigmentosum |
| Q33349721 | A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA) |
| Q39737298 | ATP-ase Activity of Lymphocytes from Patients with Carcinomas of the urinary Bladder |
| Q39605844 | Activated lymphocytes trigger lymphoblast extravasation |
| Q35818561 | Active specific immunotherapy in patients with melanoma. A clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies |
| Q41139331 | Adjuvant immunotherapy with bacillus Calmette-Guérin in prostatic cancer |
| Q64936849 | An immunological approach to the therapy of cancer? |
| Q40944481 | An immunoregulatory factor associated with spleen cells from tumor-bearing animals. I. Effect on tumor growth and antibody production |
| Q39558953 | Antigenic changes associated with liver carcinogenesis |
| Q54243636 | Antigenic inhibition of cell-mediated cytotoxicity against tumour cells. |
| Q52163390 | Antigenicity of clones of mouse prostate cells transformed in vitro |
| Q69369523 | Antigens of carcinoma of the cervix uteri. A study by means of immunofluorescence |
| Q39914802 | Approaches to the Quantitative Analysis of Delayed Hypersensitivity |
| Q39900100 | Biochemical aspects of viral transformation |
| Q40540103 | Blocking factors against melanoma leucocyte-dependent antibody: relationship to disease activity in melanoma patients |
| Q70560693 | Blocking of cell‐mediated tumor immunity by sera from patients with growing neoplasms |
| Q68646115 | Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes |
| Q48340595 | Busulfan and chloramphenicol induced T cell lymphoma: cell surface characteristics and functional properties |
| Q36235825 | CD3-mediated activation of tumor-reactive lymphocytes from patients with advanced cancer |
| Q40433269 | Can Co‐stimulated Tumor Immunity be Therapeutically Efficacious? |
| Q53589455 | Can permissible levels of carcinogenic compounds in the environment be envisaged? |
| Q48710165 | Can “Blocking” Serum Factors Protect against Autoimmunity? |
| Q73587594 | Cancer vaccines: challenges and potential solutions |
| Q67288983 | Carcinoembryonic antigen in patients suffering from ulcerative proctocolitis |
| Q66952957 | Cell-Mediated Immunity to Melanoma-Associated Antigens in Patients With Ocular Malignant Melanoma |
| Q39944336 | Cell-Mediated Immunity to Tumor Cells |
| Q71610062 | Cell-mediated immunity against antigens common to human colonic carcinomas and fetal gut Epithelium |
| Q40744447 | Cell-mediated immunity in sarcoidosis: effect of corticosteroids |
| Q34079830 | Cell-mediated tumour immunity in patients with transitional cell carcinoma of the urinary bladder |
| Q66939776 | Cellular Immunity to Canine Mammary Tumor Cells Demonstrated by the Leucocyte Migration Technique |
| Q66880112 | Cellular Immunity to Tumor-Associated Antigens in Man |
| Q71428318 | Cellular Sensitivity to Tumors |
| Q36358477 | Cellular immune responses to methylcholanthrene-induced fibrosarcoma in BALB/c mice |
| Q33461108 | Cellular immunity to autologous platelets and serum-blocking factors in idiopathic thrombocytopenic purpura |
| Q37101861 | Cerebral reticulum cell sarcoma after multiple renal transplants |
| Q40224426 | Characteristics of a low-molecular-weight factor extracted from mouse tumors that affectsin vitro properties of macrophages |
| Q40114484 | Characterization of a recombinant vaccinia virus expressing human melanoma-associated antigen p97. |
| Q40795909 | Characterization of mononuclear cells in the inflammatory infiltrates of cutaneous tumours |
| Q41879332 | Chimeric T cell receptor which incorporates the anti-tumour specificity of a monoclonal antibody with the cytolytic activity of T cells: a model system for immunotherapeutical approach |
| Q37045000 | Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients |
| Q41068595 | Circulating immune complexes in bronchogenic carcinoma: relation to extent of disease and to therapy (author's transl) |
| Q70425783 | Colon carcinoma and immunologic phenomena |
| Q33815517 | Colony inhibition of fibroblasts from chimeric dogs mediated by the dogs' own lymphocytes and specifically abrogated by their serum |
| Q71517318 | Colony inhibition studies on blocking and non-blocking serum effects on cellular immunity to moloney sarcomas |
| Q40002625 | Complement and tumor immunology. |
| Q40775189 | Concomitant Presence of Tumor-Specific Cytotoxic and Inhibitor Lymphocytes in Patients with Osteogenic Sarcoma |
| Q54236434 | Critical evaluation of histocompatibility in 179 renal transplants. |
| Q35107009 | Curing mice with large tumors by locally delivering combinations of immunomodulatory antibodies |
| Q54567146 | Cutaneous Delayed Hypersensitivity Responses of Patients with Retinoblastoma to Standard Recall Antigens and Crude Membrane Extracts of Retinoblastoma Tissue Culture Cells |
| Q69048309 | Cutaneous delayed hypersensitivity responses to tumor-associated and other antigens in acute leukemia |
| Q45972793 | Cyclophosphamide (Cy)-facilitated adoptive immunotherapy of a Cy-resistant tumour. Evidence that Cy permits the expression of adoptive T-cell mediated immunity by removing suppressor T cells rather than by reducing tumour burden. |
| Q44541649 | Cytostatic antibody and SV40 tumour immunity in hamsters |
| Q54001365 | Delayed cutaneous hypersensitivity reactions to extracts of malignant and normal breast cells. |
| Q53703630 | Demonstration of Specific Antigen in N-[4-(5-nitro-2-furyl)-2-thiazolyl] Formamide Induced Rat Bladder Tumor |
| Q40327589 | Depressed immunity and the development of cancer. |
| Q44149588 | Destruction of cultivated melanoma cells by lymphocytes from healthy black (North American Negro) donors |
| Q34106654 | Detection of Tumor-Specific Antigens in an Equine Sarcoid Cell Line |
| Q40097751 | Direct immunochemical detection of prostaglandin-e and cyclic nucleotides in human malignant tumors |
| Q70549696 | Disappearance of a tumor-associated antigen in malignant melanoma after imidazole carboxamide therapy |
| Q39577449 | Ductular carcinoma of the breast.Serum antibodies to tumor-associated antigens |
| Q40847765 | Echinococcus multilocularis in the mouse: The in vitro protoscolicidal activity of peritoneal macrophages |
| Q69135671 | Editorial: Transfer factor |
| Q54376922 | Effect of azathioprine and cytosine arabinoside on humoral and cellular immunity in vitro |
| Q40169944 | Effect of immunoglobulin G on membrane-bound enzyme activity of sarcoma 180 cells |
| Q40100736 | Efforts to explain spontaneous regression of cancer |
| Q39457581 | Electrophoretic mobility (EM)-test for childhood cancer diagnosis |
| Q34568691 | Endogenous type I interferons as a defense against tumors. |
| Q36290155 | Evaluation of leucocyte functions six years after tumour autograft in human mammary cancer |
| Q71948865 | Evaluation of the radiosensitizing effects of RK28 intravenous, intraarterial, and intratumoral injections on the rabbit VX2 tumor system |
| Q68880412 | Evidence for tumor-specific antigens in filtered tissue culture media from human cancer cells |
| Q39949988 | Experimental Teratoma |
| Q46303931 | Experimental models and the role of RNA in immunotherapy of leukemia |
| Q66952726 | Frontiers in inflammatory bowel disease. The proceedings of a conference sponsored by the McReynolds Foundation. Part II |
| Q70006504 | Generation of human cytotoxic T lymphocytes against autologous solid tumors by autologous mixed lymphocyte tumor cell culture with T cell growth factor |
| Q53845861 | High levels of free fatty acids in lymphoid cells, with special reference to their cytotoxicity. |
| Q39952473 | Histological and combined chemoimmunostimulation therapy studies against a murine leukemia |
| Q54013259 | Histological evidence of tumour rejection after active immunotherapy in human malignant disease. |
| Q40014921 | Human Tumor Immunology |
| Q41090411 | Human tumor antigens are ready to fly. |
| Q67472146 | Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells |
| Q43499556 | Hydantoin immunosuppression and carcinogenesis |
| Q41437276 | Hyperthermia (42 degrees C) as an adjuvant to radiotherapy and chemotherapy in the treatment of the allogeneic VX2 carcinoma in the rabbit |
| Q48334272 | Identification of a novel population of highly cytotoxic c-Met-expressing CD8+ T lymphocytes. |
| Q42534814 | Immune Mechanisms Are Major Players in Cancer |
| Q39773332 | Immune modulation and cancer control |
| Q39998267 | Immunity in Cancer |
| Q36290175 | Immunity to tumours of the murine leukaemia-sarcoma virus complex |
| Q39436763 | Immunogenicity of solubilized tumor antigen extracted from P1798 murine lymphoma cells or isolated from tumor-bearer ascites fluid and reactivity with anti-thy-1.2 antiserum |
| Q71589319 | Immunologic Concepts and Their Potential Role in Cancer Therapy |
| Q53923990 | Immunologic response in gynecologic malignancy as demonstrated by the delayed hypersensitivity reaction: clinical correlations. |
| Q39384841 | Immunological aspects of Hodgkin's disease |
| Q44538405 | Immunological detection of human bladder carcinoma |
| Q36771324 | Immunological studies on Burkitt's lymphoma |
| Q33967542 | Immunology, virology, and cancer |
| Q39878999 | Immunosurveillance and cancer |
| Q68959945 | Immunotherapeutic approaches to cancer control |
| Q70492433 | Immunotherapy combined with primary resection of murine fibrosarcoma: correlation of immunological status of the host with prevention of metastases |
| Q39711568 | Immunotherapy in the Treatment of Cancer |
| Q35144746 | Immunotherapy in treatment of breast cancer. |
| Q73417017 | Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cells |
| Q34469577 | In vitro stimulation of hamster lymphocytes with concanavalin A. |
| Q70343489 | In vitro studies on cell-mediated immunity following surgery in mice sensitized to syngeneic mammary tumors |
| Q53899514 | In vivo and in vitro responses to tumor-associated antigens: apparent absence of T cell participation. |
| Q36253297 | Induction of Tumor-Immune Responses and Their Interaction with the Developing Tumor |
| Q36027164 | Induction of tolerance to a murine fibrosarcoma in two zones of dosage--the involvement of suppressor cells |
| Q66957490 | Inhibition of syngeneic fibrosarcoma growth by lymphocytes sensitized on tumor-cell monolayers in the presence of the thymic humoral factor |
| Q42160029 | Interaction of antibody and cell surface localized antigen |
| Q40717006 | Introduction — Immunological Reactions and Immunotherapy of Malignant Disease |
| Q93694193 | L-asparaginase and allograft immunity |
| Q66699970 | Limits and possibilities of neoplasm immunotherapy |
| Q36936462 | Long-lasting complete regression of established mouse tumors by counteracting Th2 inflammation |
| Q34066710 | Lymphocyte Effector Molecules and Cell-Mediated Immune Reactions |
| Q53842079 | Lymphocytic reaction associated with bladder cancer. Effect of chronic immunosuppression. |
| Q54137970 | Lymphocytotoxicity in mycosis fungoides |
| Q43852778 | Macrophage electrophoretic mobility (MEM) test in malignant gynaecological diseases |
| Q70453983 | Macrophage migration inhibition with mouse tumor antigens: Properties of serum and peritoneal cells during tumor growth and after tumor loss |
| Q36270999 | Macrophage-melanoma cell heterokaryons. IV. Unmasking the macrophage-specific membrane receptor |
| Q36449055 | Malignant glial neoplasms: definition of a humoral host response to tumor-associated antigen(s) |
| Q54568713 | Modulation of the immune response to transplantation antigens. I. The effects of immunization using adjuvants on the immune response of mice to a tumour allograft |
| Q70058583 | Modulation of the immune response to transplantation antigens. III. Further studies on the effects of Freund's complete adjuvant on the immune response of mice to allogeneic tumour antigen |
| Q37542948 | Monoclonal antiidiotypic antibodies related to a murine oncofetal bladder tumor antigen induce specific cell-mediated tumor immunity |
| Q34075570 | Morphological features and functional properties of human fibroblasts exposed to Actinomyces viscosus substances |
| Q39914994 | Newer concepts of cancer of the colon and rectum: Cellular immunity to human colonic carcinomas |
| Q40569771 | Noncytotoxic, antitumor polysaccharides |
| Q52380259 | Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis. |
| Q55491395 | Organization of Clinical Trial on National Scale: Management of Early Cancer of the Breast |
| Q39928599 | Participation of Lymphocytes in Viral Infections |
| Q93694198 | Passive immunotherapy for neuroblastoma |
| Q44633687 | Peripheral Lymphocyte Counts and Results of Therapeutic Castration for Advanced Mammary Cancer |
| Q38704007 | Perspectives on the role of MHC antigens in normal and malignant cell development |
| Q39916869 | Possibilities and Problems of Immunologic Intervention in Cancer |
| Q64381660 | Prevention of Primary Simian Adenovirus Type 7 (SA7) Tumors in Hamsters by Adoptive Transfer of Lymphoid Cells: Role of Different Cell Types |
| Q46807002 | Prevention of tumor growth in an “immunologically privileged site” by adoptive transfer of tumor-specific transplantation immunity |
| Q39872197 | Principles of immunological tolerance and immunocyte receptor blockade |
| Q43883129 | Prognosis of the second breast cancer. The role of previous exposure to the first primary |
| Q44998010 | Prognostic factors in colon carcinoma: correlation of serum carcinoembryonic antigen level and tumor histopathology |
| Q33588526 | Prospects for the therapeutic use of anticancer vaccines |
| Q42440914 | Quantitative immunocytochemical study of plasma cells in skin tumoral stromal reaction |
| Q35228884 | Recent Advances in Antitumor Vaccines |
| Q33552626 | Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy |
| Q71084125 | Red Cell Immune Adherence (Rcia): Its Application in Cancer and Autoimmune Disease |
| Q69348979 | Regression of polyoma tumor metastasis by combined unblocking and bcg treatment-correlation with induced alterations in tumor immunity status |
| Q41043904 | Regulatory mechanisms of antitumor T cell responses in the tumor-bearing state |
| Q41952176 | Rejection of tumor allografts by mouse spleen cells sensitized in vitro |
| Q44446256 | Reproducibility Of The Immunofluorescent Test For Antimelanoma Antibodies |
| Q70577480 | Response of lymphocytes from patients with gastrointestinal cancer to the carcinoembryonic antigen of the human digestive system |
| Q67247600 | Role of a non-committed accessory cell in the in vivo suppression of a syngeneic tumour by immune lymphocytes |
| Q93710400 | Role of activated macrophages and antibody in inhibition and enhancement of tumour growth in rats |
| Q36101562 | Separation of lymphocytes and macrophages from suspensions of guinea pig peritonitis exudate cells using programmed gradient sedimentation |
| Q53730497 | Serogenetic investigations on malignant melanomas with reference to the incidence of AB0 system, Rh system, Gm, Inv, Hp and Gc systems |
| Q71709698 | Serum mediated inhibition of cellular immunity to methylcholanthrene-induced murine sarcomas |
| Q42856820 | Significance of serum factors modifying cellular immune responses to growing tumours |
| Q70616945 | Some aspects of the immune defense against cancerI. In vitro studies on animal tumors |
| Q70616949 | Some aspects of the immune defense against cancerII. In vitro studies on human tumors |
| Q66936265 | Specific immunoprotection with 3 M KCI solubilized tumor antigen |
| Q70413132 | Specific killing of tumor cellsIn vitro in the presence of normal lymphoid cells and sera from hosts immune to the tumor antigens |
| Q70016478 | Spontaneous tumor regression. Experimental aspects |
| Q36991945 | Studies of humoral and cell-mediated immunity in human melanoma |
| Q69110430 | Studies on in vitro models of cellular immunity: The role of T and B cells in the secretion of lymphotoxin |
| Q36335332 | Subversion of host defense mechanisms by malignant tumors: an established tumor as a privileged site for bacterial growth |
| Q37479263 | Suggestive Evidence That the “Blocking Antibodies” of Tumor-Bearing Individuals May Be Antigen-Antibody Complexes |
| Q39805019 | Suppressor Cells: Permitters and Promoters of Malignancy? |
| Q53796112 | T Lymphocytes in Bladder and Prostatic Cancer Patients |
| Q35096703 | T cell anergy and costimulation |
| Q40676323 | T lymphocyte-mediated cytotoxicity in HBsAg-positive liver disease |
| Q36335154 | T-cell-mediated concomitant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasites |
| Q39590911 | The Biology and Detection of Immune Complexes |
| Q40117800 | The Murine Antitumor Immune Response and Its Therapeutic Manipulation |
| Q40098443 | The Role of the Major Histocompatibility Gene Complex in Murine Cytotoxic T Cell Responses |
| Q39988027 | The cell surface in immune response |
| Q42145665 | The cellular immune response to carcinoma of the urinary bladder: correlation to clinical stage and treatment |
| Q72855651 | The comparative selectivity of adjuvants for humoral and cell-mediated immunity. II. Effect on delayed-type hypersensitivity in the mouse and guinea pig, and cell-mediated immunity to tumour antigens in the mouse of Freund's incomplete and complete |
| Q70540408 | The fate of circulating methylcholanthrene tumor cells in mice with tumor-specific immunity |
| Q39867469 | The future of tumor immunology |
| Q36252256 | The immune response to infection with vaccinia virus in mice: I. Infection and the production of antibody neutralizing cell-associated and cell-free virus |
| Q39862410 | The influence of embryonal bursectomy on benzpyrene-induced sarcoma of the chicken |
| Q36470749 | The next wave of recombinant and synthetic anticancer vaccines |
| Q72494202 | The red-cell immune system |
| Q71125609 | The surgeon's role in breast cancer: changing concepts |
| Q35071688 | Therapeutic vaccination with tumor cells that engage CD137. |
| Q35201619 | Tissue T and B cell infiltration of primary and metastatic cancer |
| Q69626587 | Transplantation of ethylnitrosourea--induced schwannomas in the Harvard rat |
| Q39595193 | Tumor Immunology in Domestic Animals |
| Q56876356 | Tumor Regression and Cure Depends on Sustained Th1 Responses |
| Q39148903 | Tumor growth in the absence of circulating antibodies |
| Q33991120 | Tumor immunology with particular reference to malignant melanoma |
| Q40530762 | Tumor progression and homeostasis |
| Q40000434 | Tumor-specific cellular immunity |
| Q70663165 | Tumour growth after intravenous, intraperitoneal and subcutaneous injection of syngeneic monodispersed tumour-cell suspension |
| Q54045639 | Tumour growth in nematode-infected animals. |
| Q39337109 | Tumour immunology and the gut |
| Q45496947 | Tumour prevention and rejection with recombinant vaccinia. |
| Q39744314 | Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck |
| Q34426877 | Urotherapy for patients with cancer |
| Q46991251 | Use of the defined antigen substrate spheres system as a model for analysing possible mechanisms of inhibition-blockade of anti-tumour lymphocytotoxicity |
| Q40668552 | Variability in thymectomized, irradiated mice that affects their responses to HeLa cells |
| Q39894347 | Viral genome and oncogenic transformation: nuclear and plasma membrane events |
| Q39903659 | Virion and tumor cell antigens of C-type rna tumor viruses |
| Q54308599 | [Immunobiology of cancer]. |
| Q68681234 | [Leukocyte adhesion inhibition: a simple in-vitro test for the detection of tumor-specific immunity and blocking serum factors in children with malignant neoplasms] |
| Q47132136 | cGAS/STING Pathway in Cancer: Jekyll and Hyde Story of Cancer Immune Response |
Search more.